Association of Volume Status Assessed by Bioimpedance with BP in CKD

Katherine Scovner Ravi1,2, Enass Elsayed1,2, Brendon L Neuen3

  • 1Brigham and Women's Hospital, Boston, Massachusetts.

Kidney360
|August 14, 2025
PubMed

Insights

In chronic kidney disease (CKD) patients, shorter vector length (indicating more body fluid) and decreasing vector length were linked to higher systolic blood pressure (BP). Volume status may impact hypertension management in CKD.

Area of Science:

  • Nephrology
  • Cardiovascular Medicine
  • Biomedical Engineering

Background:

  • Hypertension is prevalent in chronic kidney disease (CKD) patients, increasing cardiovascular risk.
  • Hypervolemia contributes to hypertension, but its link with volume biomarkers in CKD is not well understood.

Purpose of the Study:

  • To investigate the association between body fluid volume, assessed by vector length, and blood pressure in CKD patients.
  • To determine if changes in volume over time correlate with blood pressure changes.

Main Methods:

  • Utilized data from 5,384 CKD patients in the Chronic Renal Insufficiency Cohort (CRIC) study.
  • Employed linear regression models to analyze the relationship between vector length (bioimpedance proxy for volume) and systolic/diastolic blood pressure (BP).
  • Assessed non-linear associations and changes in vector length and BP over two years.

Main Results:

  • A non-linear association was observed between vector length and systolic BP.
  • The lowest quartile of vector length (hypervolemia) was linked to 3.2 mmHg higher systolic BP compared to the third quartile.
  • A decrease in vector length over two years was associated with a 3.0 mmHg increase in systolic BP; diastolic BP showed no association.

Conclusions:

  • Shorter and decreasing vector length are independently associated with higher and increasing systolic BP in CKD patients.
  • Further research is needed to explore if optimizing volume status using bioimpedance can improve BP control in CKD.
Abstract

No abstract available in PubMed .

Related Concept Videos

Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
55
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
67
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
80
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
91
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.1K